Managing High Cardiac Output Failure in a Patient With Hereditary Hemorrhagic Telangiectasias During Pregnancy.

Erica Lynn Smith, Robert Egerman, Arwa Saidi, Ki Park, Ali Ataya

Open access · goldAbstract readCase Reports

In one paragraph

Article in JACC. Case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 51% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Erica Lynn SmithDepartment of Obstetrics and Gynecology, University of Florida, Gainesville, Florida, USA.

Robert EgermanDepartment of Obstetrics and Gynecology, University of Florida, Gainesville, Florida, USA.

Arwa SaidiCongenital Heart Center, University of Florida, Gainesville, Florida, USA.

Ki ParkDivision of Cardiology, University of Florida, Gainesville, Florida, USA.

Ali AtayaDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Florida, USA.

University of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemorrhagic telangiectasias is a rare genetic vascular disorder that may complicate pregnancy. We report a case of a pregnant hemorrhagic telangiectasias patient with innumerable hepatic arteriovenous malformations that developed high output cardiac failure necessitating delivery. Postpartum, the patient was treated with bevacizumab that resulted in clinical improvement.

Indexed as

arteriovenous malformationbevacizumabhereditary hemorrhagic telangiectasiashigh cardiac output failureliver hemangiomapregnancy

Identifiers

PMID38094716

DOI10.1016/j.jaccas.2023.102096

PMCPMC10715985

OpenAlexW4389371433

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.